about
Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgeryAcute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project.Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group.The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy.Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study.Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.Heart failure and anemia: Effects on prognostic variables.Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias.Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score.Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.Levosimendan improves exercise performance in patients with advanced chronic heart failure.Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction.Effects of beta-blockers on ventilation efficiency in heart failure.Prognostic value of indeterminable anaerobic threshold in heart failure.Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure.Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue.Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients.Reference Values for Peak Exercise Cardiac Output in Healthy Individuals.Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.The alveolar to arterial oxygen partial pressure difference is associated with pulmonary diffusing capacity in heart failure patients.Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: effects of antihypertensive combination treatmentBlood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment EffectsCorrigendum to ‘Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project’ [Respir. Physiol. Neurobiol. 188 (2013) 223–228]Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumptionDose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillationMultiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: The CARNEBI trialChronotropic Incompentence and Functional Capacity in Chronic Heart Failure: No Role of β-Blockers and β-Blocker DoseRelationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patientsThe role of cardiopulmonary exercise tests in pulmonary arterial hypertensionPrediction of peak oxygen uptake by an endurance test: A wish and a nightmareHeart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 yearsComprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performanceIsocapnic buffering period: From physiology to clinicsDo rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters?Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction
P50
Q28242672-7C986D36-8305-4EBE-A623-248FF1D73490Q30619949-8065A918-353D-4CEF-AF87-10D7BB2DB0E9Q30961727-E9759477-364A-4CC7-BC37-79CE9B2A164BQ31030359-6170D608-C9CA-4BE4-8E52-5D1D403C3466Q31089116-36F19179-F0EA-4E16-B333-3078A4108D25Q33648781-CFD238E4-5211-412B-9286-BC7488A0400BQ34337289-42D9FDAC-1D9A-4AB5-86C8-7147CA026FE8Q34712791-A25E7A61-3C31-435F-89D2-7762D0E27D1AQ38412801-0A674173-514C-47ED-B6B4-EB76C0554B65Q38944593-B875FF57-6ECC-43A2-920D-15303578B964Q39332451-3CB829DA-F526-424E-8D6A-41CA2010C0D3Q39974993-8363D72B-FE49-4A80-99D8-61E58887FCF8Q40419769-10DB7148-B44D-450E-955E-6B910CA73592Q40603927-611908B0-24A5-4F85-BC7A-C42A344F1BA1Q41226308-ED9796AF-53B5-4E5C-8C15-EC7CC81921F2Q41280127-864D256A-3B03-4129-B36D-6138CC7D669AQ43009307-A4E2B684-1FC5-4400-9C09-3B44C0C67E8BQ45892581-47E2B835-407F-471A-9E96-34C5355B3DF9Q46306945-4D5D1D2E-4801-4728-A145-299F729B1F3DQ47420376-28751B07-AC68-4E0C-87C9-152798EB44B8Q47631869-A6494BFA-7A0C-40B2-B0E3-B5EFADE67F70Q47910475-D993B3D5-2722-4C38-96EA-D997980B464EQ48004079-D16A1808-543C-4AB9-A3B1-06D851CF2488Q49349456-644CC154-44CA-47C3-B893-9CA1C73FDE42Q51497268-DDAD0FED-052D-4435-8E12-AEC404801CB3Q57094239-EBDF813F-9FBF-4445-893C-32529A36971DQ57094873-F656B30D-ECC4-4A70-8B25-FE1D49E8EBD2Q57486771-A446A3AB-930F-4253-95CC-F26E9BD551B0Q57487277-5B3D9479-3D7A-4F16-8D9B-D1E586CC24E7Q57628365-7AF28ED2-D442-437D-B6DF-B5FA3676B743Q60808096-E42E54CD-299A-40B7-BE43-D050C3BB5ACCQ60808113-9A5F4556-3F8A-4B76-9A10-A4B982DB3917Q84331646-F4E21C4D-73C9-483F-BA1D-14A9C783A5D8Q88547761-4A2719C1-4143-4526-8A08-1A2A6A629636Q90475694-4DA261A8-8952-4573-9E82-809D13333797Q90997007-256ED907-9D5B-412B-9706-C4653725BFAFQ91341174-42DBE587-30F1-4B91-8193-C735AB0B6B58Q91515271-BE35F924-3BBE-4C2F-9069-611C2990507FQ91516810-AEA6F630-4328-48DA-9C14-4138B0B09991Q91540428-C95D7A37-5CFF-42F4-9F26-19E69B8BE453
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabetta Salvioni
@ast
Elisabetta Salvioni
@en
Elisabetta Salvioni
@es
Elisabetta Salvioni
@nl
type
label
Elisabetta Salvioni
@ast
Elisabetta Salvioni
@en
Elisabetta Salvioni
@es
Elisabetta Salvioni
@nl
prefLabel
Elisabetta Salvioni
@ast
Elisabetta Salvioni
@en
Elisabetta Salvioni
@es
Elisabetta Salvioni
@nl
P106
P1153
25936665100
P31
P496
0000-0002-8448-7551